“Cardiotoxicity in Low-to-Moderate Cardiovascular Risk Patients Undergoing Anti-HER2 Therapy: A Prospective CMR Study”. Radiology and Oncology, vol. 59, no. 4, Dec. 2025, pp. 510-21, https://www.radioloncol.com/index.php/ro/article/view/4626.